Table 2.
Participant demographics (N = 99).
n | % | |
---|---|---|
Sex | ||
Male | 75 | 75.8 |
Female | 24 | 24.2 |
Nationality | ||
Indian / Bangladeshi | 61 | 61.6 |
Singaporean | 30 | 30.3 |
Filipino | 3 | 3.0 |
Russian | 2 | 2.0 |
Bruneian | 1 | 1.0 |
Indonesian | 1 | 1.0 |
Malaysian | 1 | 1.0 |
Ethnicity | ||
Bangladeshi | 47 | 47.5 |
Chinese | 18 | 18.2 |
Indian | 17 | 17.2 |
Malaysian | 8 | 8.1 |
Filipino | 4 | 4.0 |
Russian | 2 | 2.0 |
Bruneian | 1 | 1.0 |
Indonesian | 1 | 1.0 |
Pakistani | 1 | 1.0 |
Education | ||
No formal qualification | 3 | 3.0 |
Secondary school | 30 | 30.3 |
High school | 31 | 31.3 |
Diploma/degree | 31 | 31.3 |
Post-graduate qualification | 4 | 4.0 |
Smoking status | ||
Never smoked | 75 | 75.8 |
Not currently a | 12 | 12.1 |
Yes | 12 | 12.1 |
Medical condition b | ||
No | 89 | 89.9 |
Yes | 10 | 10.1 |
Medication c | ||
No | 89 | 89.9 |
Yes | 10 | 10.1 |
“Not currently” refers to the response “Not currently, but I have in the past”.
No medical conditions relating to chemosensory dysfunction or illness were reported. There were reports of high blood pressure (n = 2), asthma (n = 1), cardiovascular issues (n = 1), diabetes (n = 1), hypertension (n = 1), hypertension and diabetes (n = 1), hypothyroid and rheumatoid arthritis (n = 1), lupus (n = 1), and diabetes, hypertension, hypersensitivity lung disease, and benign prostatic hyperplasia (n = 1).
No medication relating to, or that would affect, chemosensory function was being taken by participants. Participants reported taking losartan (n = 1), metformin (n = 1), prednisone (n = 1), albuterol inhaler (n = 1), and one reported taking irbesartan, dutasteride, rosuvastatin and aspirin (n = 1), medication for hypertension (n = 1), anti-thyroid and rheumatoid arthritis (n = 1), hypertension and diabetes (n = 1), and one reported taking insulin as well as medication for hypertension (n = 1), and one participant’s response was unclear (wrote “less”) (n = 1).